Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,936 | -148,315 | -66,649 | -55,909 | -23,674 |
| Depreciation Amortization | 25,140 | 99,711 | 69,889 | 42,768 | 19,226 |
| Income taxes - deferred | -137 | 6,746 | -10,159 | -7,424 | -3,231 |
| Accounts receivable | 9,453 | -17,082 | -16,461 | -2,268 | -714 |
| Accounts payable and accrued liabilities | 7,453 | N/A | N/A | N/A | -3,647 |
| Other Working Capital | 8,441 | -4,238 | -4,970 | -3,145 | -13,188 |
| Other Operating Activity | -27,733 | 48,429 | 17,455 | 16,055 | 6,184 |
| Operating Cash Flow | $-3,319 | $-14,749 | $-10,895 | $-9,923 | $-19,044 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -227 | -1,212 | -1,029 | -726 | -223 |
| Net Acquisitions | N/A | -87,986 | -86,177 | -80,927 | N/A |
| Other Investing Activity | 0 | 4,850 | 4,850 | 0 | 0 |
| Investing Cash Flow | $-227 | $-84,348 | $-82,356 | $-81,653 | $-223 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,000 | 7,655 | 2,655 | 596 | 3,313 |
| Debt Issued | N/A | 130,000 | 130,000 | 130,000 | N/A |
| Debt Repayment | -14,924 | -10,057 | -10,041 | -13 | -7 |
| Common Stock Issued | N/A | 395 | 276 | 276 | 144 |
| Other Financing Activity | -19 | -7,616 | -7,307 | -7,307 | -109 |
| Financing Cash Flow | $-15,943 | $120,377 | $115,583 | $123,552 | $3,341 |
| Beginning Cash Position | 56,135 | 34,855 | 34,855 | 34,855 | 34,855 |
| End Cash Position | 36,646 | 56,135 | 57,187 | 66,831 | 18,929 |
| Net Cash Flow | $-19,489 | $21,280 | $22,332 | $31,976 | $-15,926 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,319 | -14,749 | -10,895 | -9,923 | -19,044 |
| Capital Expenditure | -227 | -1,212 | -1,029 | -726 | -223 |
| Free Cash Flow | -3,546 | -15,961 | -11,924 | -10,649 | -19,267 |